DE NOVELLIS, DANILO
DE NOVELLIS, DANILO
Dipartimento di Medicina, Chirurgia e Odontoiatria “Scuola Medica Salernitana”/DIPMED
A Frail Hairy Cell Leukemia Patient Successfully Treated with Pegylated Interferon-α-2A
2023-01-01 De Novellis, D.; Giudice, V.; Ciccone, V.; Erra, P.; De Vita, A.; Picone, F.; Serio, B.; Selleri, C.
Cytomegalovirus reactivation is frequent in multiple myeloma patients treated with daratumumab-based regimens
2024-01-01 De Novellis, D.; Fontana, R.; Serio, B.; Vaccaro, E.; Guariglia, R.; Morini, D.; Rizzo, M.; Giudice, V.; Selleri, C.
Effective Neutralizing Antibody Response Against SARS-CoV-2 Virus and Its Omicron BA.1 Variant in Fully Vaccinated Hematological Patients
2023-01-01 De Novellis, D.; Folliero, V.; Giudice, V.; Pezzullo, L.; Sanna, G.; Fontana, R.; Guariglia, R.; Zannella, C.; Mettivier, L.; Ferrara, I.; Boccia, G.; Buonanno, M. T.; Martorelli, M. C.; Luponio, S.; Crudele, A.; Pagliano, P.; Sessa, A. M.; Velino, F.; Langella, M.; Manzin, A.; Galdiero, M.; Selleri, C.; Franci, G.; Serio, B.
Efficacy and safety of belantamab-mafodotin in triple-refractory multiple myeloma patients: A multicentric real-life experience
2022-01-01 Iula, R.; De Novellis, D.; Trastulli, F.; Della Pepa, R.; Fontana, R.; Carobene, A.; Di Perna, M.; D'Ambrosio, A.; Romano, M.; Leone, A.; De Fazio, L.; Fiumarella, A.; Gaeta, G.; Marafioti, V.; Barbato, S.; Palmieri, S.; Rocco, S.; Serio, B.; Califano, C.; Pane, F.; Ferrara, F.; Giudice, V.; Selleri, C.; Catalano, L.
Giant plasma cells with multiple immature nuclei in a young woman with newly diagnosed multiple myeloma
2022-01-01 Giudice, V.; De Novellis, D.; Guariglia, R.; Fumo, R.; Ciancia, G.; Serio, B.; Selleri, C.
Hemopoiesis and Immune Cell Perturbations during Venetoclax Plus Azacytidine Treatment in Acute Myeloid Leukemia
2021-01-01 Giudice, V; Ferrara, I; Gorrese, M; D'Alto, F; Guariglia, R; Luponio, S; Pezzullo, L; Mettivier, L; Bertolini, A; D'Addona, M; De Novellis, D; Cuffa, B; Serio, B; Selleri, C
Innovative Anti-CD38 and Anti-BCMA Targeted Therapies in Multiple Myeloma: Mechanisms of Action and Resistance
2023-01-01 De Novellis, D.; Fontana, R.; Giudice, V.; Serio, B.; Selleri, C.
Lenalidomide-induced psoriasis in a refractory multiple myeloma patient successfully treated with narrowband ultraviolet B
2024-01-01 De Novellis, D.; Raimondo, A.; Serio, B.; Baldi, C.; Giudice, V.; Lembo, S.; Selleri, C.
Limited efficacy of 3 + 7 plus gemtuzumab ozogamycin in newly diagnosed fit intermediate genetic risk acute myeloid leukemia patients
2024-01-01 Serio, B.; Grimaldi, F.; Ammirati, L.; Annunziata, M.; De Santis, G.; Perrotta, A.; De Novellis, D.; Giudice, V.; Morini, D.; Storti, G.; Califano, C.; Risitano, A. M.; Pane, F.; Selleri, C.
Macrophages and Urokinase Plasminogen Activator Receptor System in Multiple Myeloma: Case Series and Literature Review
2023-01-01 Manzo, Paola; Giudice, Valentina; Napolitano, Filomena; De Novellis, Danilo; Serio, Bianca; Moscato, Paolo; Montuori, Nunzia; Selleri, Carmine
Multiple myeloma characteristics correlated to serum free light chain ratio at diagnosis and association with early renal damage
2022-01-01 De Novellis, D; Carobene, A; Fontana, R; Serio, B; Ferrara, I; Martorelli, Mc; Mettivier, L; Guariglia, R; Luponio, S; Ruggiero, I; Giudice, V; Selleri, C
Non-invasive prenatal test identifies circulating cell-free DNA chromosomal abnormalities derived from clonal hematopoiesis in aggressive hematological malignancies
2024-01-01 Giudice, V.; Ianniello, M.; De Novellis, D.; Pezzullo, L.; Petrillo, N.; Serio, B.; D'Addona, M.; Della Corte, A. M.; Rizzo, M.; Cuffa, B.; Castaldi, M. A.; Savarese, P.; Mori, A.; Castiello, R.; Fico, A.; Savarese, G.; Selleri, C.
Post-Transplant Cyclophosphamide versus Anti-Thymocyte Globulin in Patients with Hematological Malignancies Treated with Allogeneic Hematopoietic Stem Cell Transplantation from Haploidentical and Matched Unrelated Donors: A Real-Life Experience
2024-01-01 Serio, B.; Storti, G.; D'Addona, M.; Santoro, L.; Frieri, C.; De Novellis, D.; Marano, L.; De Santis, G.; Guariglia, R.; Manfra, I.; Urciuoli, E.; Luponio, S.; Marotta, S.; Morini, D.; Rizzo, M.; Palmieri, F.; Cantore, N.; Giudice, V.; Risitano, A. M.; Selleri, C.
Safety of Subcutaneous Daratumumab in Anti-CD38 Monoclonal Antibody-Naïve Patients with Plasma Cell Disorders: A Multicenter Real-Life Experience
2023-01-01 De Novellis, D.; Fontana, R.; Palmieri, S.; Della Pepa, R.; Di Perna, M.; Cetani, G.; Esposito, D.; Amendola, A.; Delle Cave, G.; Serio, B.; Morini, D.; Rizzo, M.; Mettivier, L.; Trastulli, F.; Rocco, S.; Pagano, A.; Barbato, S.; Leone, A.; La Magna, M.; Bianco, R.; Rascato, G.; Carobene, A.; Cuffa, B.; Iannalfo, M.; Giudice, V.; Svanera, G.; Annunziata, M.; Pizzuti, M.; Frigeri, F.; Califano, C.; Ferrara, F.; Pane, F.; Selleri, C.
SERUM FREE LIGHT CHAIN RATIO AS A BIOMARKER OF MULTIPLE MYELOMA PROGRESSION AND ASSOCIATED RENAL DISEASE
2022-01-01 De Novellis, D; Carobene, A; Fontana, R; Serio, B; Ferrara, I; Martorelli, M; Guariglia, R; Luponio, S; Ruggiero, I; Giudice, V; Selleri, C
Subclones with variants of uncertain clinical significance might contribute to ineffective hemopoiesis and leukemia predisposition
2023-01-01 Giudice, V.; Serio, B.; Errichiello, S.; Ferrara, I.; Galdiero, A.; Bertolini, A.; Visconti, R.; De Novellis, D.; Guariglia, R.; Luponio, S.; Morini, D.; Della Corte, A. M.; Sessa, A. M.; Verdesca, F.; Langella, M.; Izzo, B.; Selleri, C.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A Frail Hairy Cell Leukemia Patient Successfully Treated with Pegylated Interferon-α-2A | 1-gen-2023 | De Novellis, D.; Giudice, V.; Ciccone, V.; Erra, P.; De Vita, A.; Picone, F.; Serio, B.; Selleri, C. | |
| Cytomegalovirus reactivation is frequent in multiple myeloma patients treated with daratumumab-based regimens | 1-gen-2024 | De Novellis, D.; Fontana, R.; Serio, B.; Vaccaro, E.; Guariglia, R.; Morini, D.; Rizzo, M.; Giudice, V.; Selleri, C. | |
| Effective Neutralizing Antibody Response Against SARS-CoV-2 Virus and Its Omicron BA.1 Variant in Fully Vaccinated Hematological Patients | 1-gen-2023 | De Novellis, D.; Folliero, V.; Giudice, V.; Pezzullo, L.; Sanna, G.; Fontana, R.; Guariglia, R.; Zannella, C.; Mettivier, L.; Ferrara, I.; Boccia, G.; Buonanno, M. T.; Martorelli, M. C.; Luponio, S.; Crudele, A.; Pagliano, P.; Sessa, A. M.; Velino, F.; Langella, M.; Manzin, A.; Galdiero, M.; Selleri, C.; Franci, G.; Serio, B. | |
| Efficacy and safety of belantamab-mafodotin in triple-refractory multiple myeloma patients: A multicentric real-life experience | 1-gen-2022 | Iula, R.; De Novellis, D.; Trastulli, F.; Della Pepa, R.; Fontana, R.; Carobene, A.; Di Perna, M.; D'Ambrosio, A.; Romano, M.; Leone, A.; De Fazio, L.; Fiumarella, A.; Gaeta, G.; Marafioti, V.; Barbato, S.; Palmieri, S.; Rocco, S.; Serio, B.; Califano, C.; Pane, F.; Ferrara, F.; Giudice, V.; Selleri, C.; Catalano, L. | |
| Giant plasma cells with multiple immature nuclei in a young woman with newly diagnosed multiple myeloma | 1-gen-2022 | Giudice, V.; De Novellis, D.; Guariglia, R.; Fumo, R.; Ciancia, G.; Serio, B.; Selleri, C. | |
| Hemopoiesis and Immune Cell Perturbations during Venetoclax Plus Azacytidine Treatment in Acute Myeloid Leukemia | 1-gen-2021 | Giudice, V; Ferrara, I; Gorrese, M; D'Alto, F; Guariglia, R; Luponio, S; Pezzullo, L; Mettivier, L; Bertolini, A; D'Addona, M; De Novellis, D; Cuffa, B; Serio, B; Selleri, C | |
| Innovative Anti-CD38 and Anti-BCMA Targeted Therapies in Multiple Myeloma: Mechanisms of Action and Resistance | 1-gen-2023 | De Novellis, D.; Fontana, R.; Giudice, V.; Serio, B.; Selleri, C. | |
| Lenalidomide-induced psoriasis in a refractory multiple myeloma patient successfully treated with narrowband ultraviolet B | 1-gen-2024 | De Novellis, D.; Raimondo, A.; Serio, B.; Baldi, C.; Giudice, V.; Lembo, S.; Selleri, C. | |
| Limited efficacy of 3 + 7 plus gemtuzumab ozogamycin in newly diagnosed fit intermediate genetic risk acute myeloid leukemia patients | 1-gen-2024 | Serio, B.; Grimaldi, F.; Ammirati, L.; Annunziata, M.; De Santis, G.; Perrotta, A.; De Novellis, D.; Giudice, V.; Morini, D.; Storti, G.; Califano, C.; Risitano, A. M.; Pane, F.; Selleri, C. | |
| Macrophages and Urokinase Plasminogen Activator Receptor System in Multiple Myeloma: Case Series and Literature Review | 1-gen-2023 | Manzo, Paola; Giudice, Valentina; Napolitano, Filomena; De Novellis, Danilo; Serio, Bianca; Moscato, Paolo; Montuori, Nunzia; Selleri, Carmine | |
| Multiple myeloma characteristics correlated to serum free light chain ratio at diagnosis and association with early renal damage | 1-gen-2022 | De Novellis, D; Carobene, A; Fontana, R; Serio, B; Ferrara, I; Martorelli, Mc; Mettivier, L; Guariglia, R; Luponio, S; Ruggiero, I; Giudice, V; Selleri, C | |
| Non-invasive prenatal test identifies circulating cell-free DNA chromosomal abnormalities derived from clonal hematopoiesis in aggressive hematological malignancies | 1-gen-2024 | Giudice, V.; Ianniello, M.; De Novellis, D.; Pezzullo, L.; Petrillo, N.; Serio, B.; D'Addona, M.; Della Corte, A. M.; Rizzo, M.; Cuffa, B.; Castaldi, M. A.; Savarese, P.; Mori, A.; Castiello, R.; Fico, A.; Savarese, G.; Selleri, C. | |
| Post-Transplant Cyclophosphamide versus Anti-Thymocyte Globulin in Patients with Hematological Malignancies Treated with Allogeneic Hematopoietic Stem Cell Transplantation from Haploidentical and Matched Unrelated Donors: A Real-Life Experience | 1-gen-2024 | Serio, B.; Storti, G.; D'Addona, M.; Santoro, L.; Frieri, C.; De Novellis, D.; Marano, L.; De Santis, G.; Guariglia, R.; Manfra, I.; Urciuoli, E.; Luponio, S.; Marotta, S.; Morini, D.; Rizzo, M.; Palmieri, F.; Cantore, N.; Giudice, V.; Risitano, A. M.; Selleri, C. | |
| Safety of Subcutaneous Daratumumab in Anti-CD38 Monoclonal Antibody-Naïve Patients with Plasma Cell Disorders: A Multicenter Real-Life Experience | 1-gen-2023 | De Novellis, D.; Fontana, R.; Palmieri, S.; Della Pepa, R.; Di Perna, M.; Cetani, G.; Esposito, D.; Amendola, A.; Delle Cave, G.; Serio, B.; Morini, D.; Rizzo, M.; Mettivier, L.; Trastulli, F.; Rocco, S.; Pagano, A.; Barbato, S.; Leone, A.; La Magna, M.; Bianco, R.; Rascato, G.; Carobene, A.; Cuffa, B.; Iannalfo, M.; Giudice, V.; Svanera, G.; Annunziata, M.; Pizzuti, M.; Frigeri, F.; Califano, C.; Ferrara, F.; Pane, F.; Selleri, C. | |
| SERUM FREE LIGHT CHAIN RATIO AS A BIOMARKER OF MULTIPLE MYELOMA PROGRESSION AND ASSOCIATED RENAL DISEASE | 1-gen-2022 | De Novellis, D; Carobene, A; Fontana, R; Serio, B; Ferrara, I; Martorelli, M; Guariglia, R; Luponio, S; Ruggiero, I; Giudice, V; Selleri, C | |
| Subclones with variants of uncertain clinical significance might contribute to ineffective hemopoiesis and leukemia predisposition | 1-gen-2023 | Giudice, V.; Serio, B.; Errichiello, S.; Ferrara, I.; Galdiero, A.; Bertolini, A.; Visconti, R.; De Novellis, D.; Guariglia, R.; Luponio, S.; Morini, D.; Della Corte, A. M.; Sessa, A. M.; Verdesca, F.; Langella, M.; Izzo, B.; Selleri, C. |